Wound Biologics Market - Global Industry Analysis, Size, Growth, Trends and Forecast 2017 - 2025
- Transparency Market Research
- January 2036
- 0 pages
The skin is one of the most vital organs in the human body. The skin acts as a protective barrier between the external environment and the environment inside the body. The skin helps preserve moisture in the body. The skin controls the body temperature. Also, it regulates the body temperature through sweating. The skin shields the body from harmful bacteria. The skin has several nerve ends, which help in responding to pressure, heat, touch, pain, and cold. Wound healing is a complex process that involves the activation and synchronization of intracellular, intercellular, and extracellular elements. Wound healing comprises various processes such as coagulation and inflammation events, fibrous tissue accumulation, deposition of collagen, epithelialization (formation of covering of the epithelial cells), wound size reduction, formation of granulation tissue, and restoration. Generally, wound is healed with tissue regeneration and scar formation. Disruptions of a wound are caused by insufficient blood flow, tissue damage, and comorbid disease states can lead to a chronic wound that is difficult to manage. Various latest advancements have occurred in the wound healing technology including skin substitutes, biologics, scaffolds, and bio-membranes.
Biologic wound healing treatments are intended to facilitate the restoration of the natural repair mechanism. They may comprise active biological agents such as plant-derived active biomolecules that exhibit antimicrobial, antioxidant, or anti-inflammatory properties. The global wound biologics market has been segmented based on product type, wound type, and geography. In terms of product type, the wound biologics market has been categorized into biologic skin substitutes, enzyme-based formulations, and growth factors. Biologic skin substitutes have a wide range of applications. The segment is expected to hold a leading share of the wound biologics market in the near future. Based on wound type, the wound biologics market has been segmented into acute wounds, chronic wounds, and surgical wounds.
Geographically, the global wound biologics market has been classified into five regions viz. North America (U.S. and Canada), Europe (Germany, France, U.K., etc.) and Asia Pacific (China, Japan, Australia, India, etc.), Latin America (Brazil and Mexico), and Middle East & Africa (the UAE, Saudi Arabia, and South Africa). In 2016, North America was a leading market for wound biologics, in terms of revenue, owing to increasing prevalence of chronic diseases and rising demand for recombinant factors. North America was followed by Europe in same year. The market in North America is expected to register a high growth during the forecast period. Emerging markets such as Asia Pacific, Latin America, and Middle East & Africa are expected to witness high growth from 2017 to 2025 due to growing health care industry and increased patient population in these regions. Among developing countries, the market in China, Brazil, and India is expected to witness robust growth between 2017 and 2025, due to increasing investments by governments of these countries to improve health care facilities.
The global wound biologics market is expected to be driven by rising prevalence of chronic wounds such as diabetic foot ulcers, leg ulcers, and pressure ulcers; increasing incidence of burns; and growing number of fire accidents. Apart from this, increase in harmful accidents involving use of acid, rise in the prevalence of skin diseases, and surge in the number of body surgeries are likely to fuel the global wound biologics market during the forecast period. However, inadequate availability of clinical data and limited regulatory product approvals act as restraints for the market.
Major players operating in the global wound biologics market are Avita Medical, Integra LifeSciences Corporation, ConvaTec Group plc, Cytori Therapeutics, Inc., Mylan N.V., Molyncke Health Care, Johnson & Johnson, Leap Therapeutics, Inc., Smith & Nephew, Nuo Therapeutics, Inc., Osiris Therapeutics, Inc., and Mallinckrodt plc.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
The study is a source of reliable data on:
- Market segments and sub-segments
- Market trends and dynamics
- Supply and demand
- Market size
- Current trends/opportunities/challenges
- Competitive landscape
- Technological breakthroughs
- Value chain and stakeholder analysis
The regional analysis covers:
- North America (U.S. and Canada)
- Latin America (Mexico, Brazil, Peru, Chile, and others)
- Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
- Eastern Europe (Poland and Russia)
- Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
- Middle East and Africa (GCC, Southern Africa, and North Africa)
The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.
A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.
Highlights of the report:
- A complete backdrop analysis, which includes an assessment of the parent market
- Important changes in market dynamics
- Market segmentation up to the second or third level
- Historical, current, and projected size of the market from the standpoint of both value and volume
- Reporting and evaluation of recent industry developments
- Market shares and strategies of key players
- Emerging niche segments and regional markets
- An objective assessment of the trajectory of the market
- Recommendations to companies for strengthening their foothold in the market
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.
Have query on this report?Make an Enquiry
The team was the biggest help to us. Not only were we provided with customized solutions but also we were guided through the most complicated situations. The information was on-point yet comprehensive. The experience was absolutely satisfying and helped us turn many challenges into opportunities.
Ours is a startup with a unique set of challenges and we were therefore hesitant but the team totally put us at ease with their knowledge and expertise. Our business and its challenges were understood perfectly and help was extended accordingly. The tailor made approach really helped us gain the most informative insights.
The report repository is absolutely impressive –updated and exhaustive in terms of markets covered and information provides. Besides, with the support extended to us by the team, we could reduce costs as well as move to sustainable growth. This really helped us tap into new opportunities. Happy to have gone ahead with ResearchMos.us.
We have had a long term engagement with ResearchMoz.us and never have we felt that the work done and help extended were below flawless. The report repository is one of the best one can hope to tap into. Recently, our partner businesses opted for consultancy services and they are all thrilled with the outcome.
Insights from reports helped us improve our profit margins significantly. Most of the knowledge we needed on the market were provided to us on a granular basis. From trends, and drivers to competitive analysis, the information was not just crisp but also insightful. That helped us chart a robust growth strategy and as of now we are happy to state that we are reaping big benefits.
More from Biotechnology
Pharmaceuticals and HealthcareGlobal Bionic Ears Market Professional Survey Report 2017
Pharmaceuticals and HealthcareNeuropsychiatric Disorder Cluster Drug Development Pipeline Review, 2017
Pharmaceuticals and HealthcareHepatitis Drug Development Pipeline Review, 2017